Towards Stratified Medicine in Plasma Cell Myeloma

Plasma cell myeloma is a clinically heterogeneous malignancy accounting for approximately one to 2% of newly diagnosed cases of cancer worldwide. Treatment options, in addition to long-established cytotoxic drugs, include autologous stem cell transplant, immune modulators, proteasome inhibitors and...

Descripción completa

Detalles Bibliográficos
Autores principales: Egan, Philip, Drain, Stephen, Conway, Caroline, Bjourson, Anthony J., Alexander, H. Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085784/
https://www.ncbi.nlm.nih.gov/pubmed/27775669
http://dx.doi.org/10.3390/ijms17101760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085784/
https://www.ncbi.nlm.nih.gov/pubmed/27775669
http://dx.doi.org/10.3390/ijms17101760

Ejemplares similares